SCHEMBL3367393

SCHEMBL3367393

Cc1ccc(S(=O)(=O)N2CCCC2c2nnc(-c3cccnc3)o2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.51
TP53 P04637 3/20 0.51
ALDH1A1 P00352 4/20 0.49
NPSR1 Q6W5P4 2/20 0.48
RAB9A P51151 2/20 0.48
NPC1 O15118 1/20 0.48
USP2 O75604 1/20 0.48
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP11B1 P15538 1/20 0.46
CYP11B2 P19099 1/20 0.46
GAA P10253 1/20 0.46
ADRB2 P07550 1/20 0.45
TSHR P16473 1/20 0.45
CA2 P00918 1/20 0.44
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3370573 0.89 MAPT (0.55) MAPTTP53NPSR1RAB9ANPC1
SCHEMBL3367394 0.87 NPSR1 (0.49) MAPTTP53ALDH1A1NPSR1USP2
SCHEMBL3367326 0.79 KDM4E (0.53) MAPTTP53ALDH1A1RAB9ANPC1
SCHEMBL3366695 0.79 GAA (0.48) MAPTTP53RAB9AGAAKMT2A
SCHEMBL6178010 0.79 CYP3A4 (0.74) MAPTTP53ALDH1A1USP2CYP3A4
SCHEMBL3364395 0.78 ALDH1A1 (0.49) ALDH1A1NPSR1RAB9ANPC1CYP3A4
SCHEMBL6068971 0.77 HTT (0.51) MAPTTP53ALDH1A1USP2MAPK1
SCHEMBL3370579 0.76 MAPT (0.48) MAPTTP53ALDH1A1NPSR1GAA
SCHEMBL3369449 0.76 ALDH1A1 (0.46) MAPTALDH1A1NPSR1RAB9ANPC1
SCHEMBL3369442 0.74 ALDH1A1 (0.44) MAPTALDH1A1NPSR1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532141-B1 2-PYRROLIDIN-2-YL- [1,3,4]-OXADIAZOLE DERIVATIVES AND THE USE OF THE SAME AS ANTIDEPRESSANTS GRUENENTHAL GMBH (DE) 2010-10-13 EP disclosed
US-7105538-B2 2-pyrrolidin-2-yl-[1,3,4]-oxadiazole compounds and their use as anti-depressants GRUENENTHAL GMBH (DE) 2006-09-12 US disclosed
US-20050187260-A1 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazole compounds and their use as anti-depressants GRUENENTHAL GMBH (DE) 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187260-A1 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazole compounds and their use as anti-depressants OPRD1, OPRK1, GRIN2C MAPT 1363/4885TP53 4832/4885ALDH1A1 510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.